Rezolute (RZLT) Other Accumulated Expenses (2014 - 2023)
Rezolute's (RZLT) quarterly Other Accumulated Expenses came in at $1.1 million in Q1 2023, up 46.73% year-on-year from $764000.0 in Q1 2022, and up 4.67% quarter-over-quarter from $1.1 million in Q4 2022.
Rezolute (RZLT) Other Accumulated Expenses (2014 - 2023) Analysis & Trends
Rezolute has disclosed Other Accumulated Expenses across 10 years of filings, most recently posting $1.1 million for Q1 2023.
- Other Accumulated Expenses for Q1 2023 came in at $1.1 million, up 46.73% year-over-year; the trailing twelve-month figure through Mar 2023 was $1.1 million (up 46.73% YoY), and the FY2022 annual result was $243000.0, down 30.37% from the prior year.
- Other Accumulated Expenses came in at $1.1 million for Q1 2023 at Rezolute, up from $1.1 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $1.1 million in Q1 2023 to a low of $121000.0 in Q3 2021.
- The 5-year median for Other Accumulated Expenses is $324500.0 (2020), against an average of $455357.1.
- Across the five-year window, Other Accumulated Expenses plunged 59.67% in 2021 and surged 124.53% in 2022, its largest moves.
- Rezolute's Other Accumulated Expenses stood at $641000.0 in 2019, then slipped by 15.29% to $543000.0 in 2020, then retreated by 12.15% to $477000.0 in 2021, then surged by 124.53% to $1.1 million in 2022, then advanced by 4.67% to $1.1 million in 2023.
- The last three Other Accumulated Expenses figures came in at $1.1 million (Q1 2023), $1.1 million (Q4 2022), and $122000.0 (Q3 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Rezolute | 425.23 Mn | 425.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Sep 30, 2022 | 122,000.00 |
| Jun 30, 2022 | 243,000.00 |
| Mar 31, 2022 | 764,000.00 |
| Dec 31, 2021 | 477,000.00 |
| Sep 30, 2021 | 121,000.00 |
| Jun 30, 2021 | 349,000.00 |
| Dec 31, 2020 | 543,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Jun 30, 2020 | 180,000.00 |
| Mar 31, 2020 | 284,000.00 |
| Dec 31, 2019 | 641,000.00 |
| Sep 30, 2019 | 159,000.00 |
| Sep 30, 2018 | 132,922.00 |
| Jun 30, 2018 | 114,000.00 |
| Mar 31, 2018 | 121,705.00 |
| Dec 31, 2017 | 116,234.00 |
| Sep 30, 2017 | 110,765.00 |
| Jun 30, 2017 | 105,295.00 |